Life Sciences

GA Agri


International Investment PDF

  • In Georgia, we have the resources to assist you in getting ideas researched, tested, commercialized, produced, and then delivered quickly to most anywhere in the world.
  • In 2019, Georgia exports of medical devices and pharmaceuticals increased 8% over 2018 setting a new record of $1.9 billion. In addition to global access, Georgia provides the innovative talent to harness the growth of technology and the impact on various sectors of life science and health IT.
  • Georgia ranks 2nd in the nation for the share of its universities’ research that is funded by industry (10.6%), a reflection of the close ties between academic research and industrial innovation in Georgia. The state’s research universities – which generate more than $2 billion a year in public and private R&D funding – work closely together. That’s largely because of the Georgia Research Alliance (GRA), which expands research lab capacity (in talent and technology). Since its founding in 1990, GRA has become the national model for university research collaboration and public-private investment.
  • The state is also home to the U.S. Centers for Disease Control and Prevention (CDC), American Cancer Society, Arthritis Foundation, CARE (Cooperation for Assistance and Relief Everywhere), The Carter Center, and the Task Force for Global Health.

For more information on Life Sciences in Georgia:

Recent Investments:

Belgian Pharma Giant UCB Planning $47.5 million Expansion, Will Create 100 Jobs in Smyrna, Georgia

Contact Info Georgia

Contact Name:
Sérgio Domingues, Managing Director

State of Georgia Europe Office
Max-Weber-Platz 11
81675 Munich   
Phone: +49 89 517 027 40
Mobile: +49 175 534 2298


C.A.S.E. aisbl Call Centre

(Belgian registered international non-profit-organisation BE07.647.874.91)

+32 488 331 972

This email address is being protected from spambots. You need JavaScript enabled to view it.

Mon - Fri: 10:00 - 16:00 C.E.T.